Diagnostic and Severity-Tracking Biomarkers for Autism Spectrum Disorder
暂无分享,去创建一个
J. Osredkar | N. Meguid | S. Chirumbolo | Geir Bjorklund | J. Aaseth | Maryam Dadar | A. El-Ansary | Maha Hemimi | M. El-Bana
[1] F. De Luca. Endocrinological Abnormalities in Autism. , 2016, Seminars in pediatric neurology.
[2] M. Chartrand,et al. How important is tryptophan in human health? , 2019, Critical reviews in food science and nutrition.
[3] S. Chirumbolo,et al. Plasma concentrations of the trace elements copper, zinc and selenium in Brazilian children with autism spectrum disorder. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[4] M. Rahman,et al. Toxic metal(loid)‐based pollutants and their possible role in autism spectrum disorder , 2018, Environmental research.
[5] S. Chirumbolo,et al. The Use of Multi-parametric Biomarker Profiles May Increase the Accuracy of ASD Prediction , 2018, Journal of Molecular Neuroscience.
[6] F. Laurindo,et al. Implications of plasma thiol redox in disease. , 2018, Clinical science.
[7] S. Chirumbolo,et al. Metabolism-Associated Markers and Childhood Autism Rating Scales (CARS) as a Measure of Autism Severity , 2018, Journal of Molecular Neuroscience.
[8] S. Scherer,et al. Progress in the genetics of autism spectrum disorder , 2018, Developmental medicine and child neurology.
[9] S. Chirumbolo,et al. Impaired lipid metabolism markers to assess the risk of neuroinflammation in autism spectrum disorder , 2018, Metabolic Brain Disease.
[10] S. Chirumbolo,et al. In the search for reliable biomarkers for the early diagnosis of autism spectrum disorder: the role of vitamin D , 2018, Metabolic Brain Disease.
[11] S. Chirumbolo,et al. Relationship between absolute and relative ratios of glutamate, glutamine and GABA and severity of autism spectrum disorder , 2018, Metabolic Brain Disease.
[12] A. Holmgren,et al. The role of the thioredoxin/thioredoxin reductase system in the metabolic syndrome: towards a possible prognostic marker? , 2018, Cellular and Molecular Life Sciences.
[13] E. Susser,et al. Prenatal fever and autism risk , 2017, Molecular Psychiatry.
[14] Salvatore Chirumbolo,et al. Cerebral hypoperfusion in autism spectrum disorder. , 2018, Acta neurobiologiae experimentalis.
[15] Geir Bjorklund,et al. Randomized controlled trial of vitamin D supplementation in children with autism spectrum disorder , 2018, Journal of child psychology and psychiatry, and allied disciplines.
[16] M. Azeem,et al. Use of N-Acetylcysteine in Psychiatric Conditions among Children and Adolescents: A Scoping Review , 2017, Cureus.
[17] A. Vasquez. Biological plausibility of the gut–brain axis in autism , 2017, Annals of the New York Academy of Sciences.
[18] H. Stevens,et al. The role of IL-6 in neurodevelopment after prenatal stress , 2017, Brain, Behavior, and Immunity.
[19] M. Tremblay,et al. Enkephalins: Endogenous Analgesics with an Emerging Role in Stress Resilience , 2017, Neural plasticity.
[20] Geir Bjorklund,et al. Assessment of gender and age effects on serum and hair trace element levels in children with autism spectrum disorder , 2017, Metabolic Brain Disease.
[21] S. Chirumbolo,et al. Tryptophan status in autism spectrum disorder and the influence of supplementation on its level , 2017, Metabolic Brain Disease.
[22] S. Chirumbolo,et al. Predictive value of selected biomarkers related to metabolism and oxidative stress in children with autism spectrum disorder , 2017, Metabolic Brain Disease.
[23] S. Chirumbolo,et al. The Role of Vitamin D in the Immune System as a Pro-survival Molecule. , 2017, Clinical therapeutics.
[24] M. Chartrand,et al. Manganese exposure and neurotoxic effects in children , 2017, Environmental research.
[25] R. Bernier,et al. Next Generation Sequencing Mitochondrial DNA Analysis in Autism Spectrum Disorder , 2017, Autism research : official journal of the International Society for Autism Research.
[26] M. Chahrour,et al. Candidate Genes for Inherited Autism Susceptibility in the Lebanese Population , 2017, Scientific Reports.
[27] Geir Bjorklund,et al. Relationship between selenium, lead, and mercury in red blood cells of Saudi autistic children , 2017, Metabolic Brain Disease.
[28] Stephen J. Guter,et al. Leveraging blood serotonin as an endophenotype to identify de novo and rare variants involved in autism , 2017, Molecular Autism.
[29] S. J. James,et al. Mathematical modeling of the methionine cycle and transsulfuration pathway in individuals with autism spectrum disorder. , 2017, Journal of theoretical biology.
[30] N. Meguid,et al. Expression of Reactive Oxygen Species–Related Transcripts in Egyptian Children With Autism , 2017, Biomarker insights.
[31] Y. Goto,et al. Associations of acute and chronic stress hormones with cognitive functions in autism spectrum disorder , 2017, Neuroscience.
[32] Mira Park,et al. Difference in mitochondrial DNA copy number in peripheral blood cells between probands with autism spectrum disorders and their unaffected siblings , 2017, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.
[33] Wim E Crusio,et al. Gene-Environment Interactions in Neurodevelopmental Disorders , 2017, Neural plasticity.
[34] T. Borody,et al. Microbiota Transfer Therapy alters gut ecosystem and improves gastrointestinal and autism symptoms: an open-label study , 2017, Microbiome.
[35] E. Hsiao,et al. Interactions between the microbiota, immune and nervous systems in health and disease , 2017, Nature Neuroscience.
[36] Uwe Kruger,et al. Significant Association of Urinary Toxic Metals and Autism-Related Symptoms—A Nonlinear Statistical Analysis with Cross Validation , 2017, PloS one.
[37] A. Nasrat,et al. Autism; An Approach for Definite Etiology and Definitive Etiologic Management , 2017 .
[38] S. Chirumbolo,et al. Role of oxidative stress and antioxidants in daily nutrition and human health. , 2017, Nutrition.
[39] L. Croen,et al. Association Between Influenza Infection and Vaccination During Pregnancy and Risk of Autism Spectrum Disorder , 2017, JAMA pediatrics.
[40] Geir Bjorklund,et al. Hair toxic and essential trace elements in children with autism spectrum disorder , 2017, Metabolic Brain Disease.
[41] F. Beheshti,et al. Protective Effect of PPARγ Agonists on Cerebellar Tissues Oxidative Damage in Hypothyroid Rats , 2016, Neurology research international.
[42] B. Dale,et al. Oxidative stress and alterations in DNA methylation: two sides of the same coin in reproduction. , 2016, Reproductive biomedicine online.
[43] Vikas Kumar,et al. Heavy metals (Pb, Cd, As and MeHg) as risk factors for cognitive dysfunction: A general review of metal mixture mechanism in brain. , 2016, Environmental toxicology and pharmacology.
[44] M. Baumgartner,et al. Autism in patients with propionic acidemia. , 2016, Molecular genetics and metabolism.
[45] M. Ghaffari,et al. Increased Serum Levels of Tumor Necrosis Factor-Alpha, Resistin, and Visfatin in the Children with Autism Spectrum Disorders: A Case-Control Study , 2016, Neurology research international.
[46] J. Bressler,et al. Role of Metabolic Genes in Blood Aluminum Concentrations of Jamaican Children with and without Autism Spectrum Disorder , 2016, International journal of environmental research and public health.
[47] Mark H Johnson,et al. Mitochondrial Dysfunction in Autism Spectrum Disorders. , 2016, Autism-open access.
[48] Geir Bjorklund,et al. Vitamin D status in autism spectrum disorders and the efficacy of vitamin D supplementation in autistic children , 2016, Nutritional neuroscience.
[49] Lisa K. Sykes,et al. The relationship between mercury and autism: A comprehensive review and discussion. , 2016, Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements.
[50] G. Laviola,et al. Genes and sex hormones interaction in neurodevelopmental disorders , 2016, Neuroscience & Biobehavioral Reviews.
[51] P. McGuire,et al. Peripheral oxytocin and vasopressin: Biomarkers of psychiatric disorders? A comprehensive systematic review and preliminary meta-analysis , 2016, Psychiatry Research.
[52] K. Schofield. Autism, Chemicals, Probable Cause and Mitigation: A New Examination , 2016 .
[53] N. Meguid,et al. Altered urinary porphyrins and mercury exposure as biomarkers for autism severity in Egyptian children with autism spectrum disorder , 2016, Metabolic Brain Disease.
[54] Geir Bjorklund,et al. The positive association between elevated blood lead levels and brain-specific autoantibodies in autistic children from low lead-polluted areas , 2016, Metabolic Brain Disease.
[55] Geir Bjorklund,et al. Mercury as a possible link between maternal obesity and autism spectrum disorder. , 2016, Medical hypotheses.
[56] J. Veenstra-VanderWeele,et al. The serotonin system in autism spectrum disorder: From biomarker to animal models , 2016, Neuroscience.
[57] Sarah Wong,et al. Autism, Mitochondria and Polybrominated Diphenyl Ether Exposure. , 2016, CNS & neurological disorders drug targets.
[58] H. Yamada,et al. Oxidative Stress and Nitric Oxide in Autism Spectrum Disorder and Other Neuropsychiatric Disorders. , 2016, CNS & neurological disorders drug targets.
[59] C. McDougle,et al. A randomized placebo-controlled pilot study of N-acetylcysteine in youth with autism spectrum disorder , 2016, Molecular Autism.
[60] Takeo Fujiwara,et al. Chemicals, Nutrition, and Autism Spectrum Disorder: A Mini-Review , 2016, Front. Neurosci..
[61] Jun Tan,et al. The role of heparan sulfate deficiency in autistic phenotype: potential involvement of Slit/Robo/srGAPs-mediated dendritic spine formation , 2016, Neural Development.
[62] Geir Bjorklund,et al. Evaluation of whole blood zinc and copper levels in children with autism spectrum disorder , 2016, Metabolic Brain Disease.
[63] A. El-Ansary. Data of multiple regressions analysis between selected biomarkers related to glutamate excitotoxicity and oxidative stress in Saudi autistic patients , 2016, Data in brief.
[64] A. Guastella,et al. The effect of oxytocin nasal spray on social interaction deficits observed in young children with autism: a randomized clinical crossover trial , 2015, Molecular Psychiatry.
[65] Salvatore Chirumbolo,et al. Immune dysfunction and neuroinflammation in autism spectrum disorder. , 2016, Acta neurobiologiae experimentalis.
[66] Geir Bjorklund,et al. The levels of blood mercury and inflammatory-related neuropeptides in the serum are correlated in children with autism spectrum disorder , 2016, Metabolic Brain Disease.
[67] S. Rombouts,et al. White matter microstructure in a genetically defined group at increased risk of autism symptoms, and a comparison with idiopathic autism: an exploratory study , 2015, Brain Imaging and Behavior.
[68] E. Fombonne,et al. Obesity and Autism , 2015, Pediatrics.
[69] Youhe Gao,et al. Urinary Biomarkers of Brain Diseases , 2015, Genom. Proteom. Bioinform..
[70] Yu Han,et al. Abnormal transsulfuration metabolism and reduced antioxidant capacity in Chinese children with autism spectrum disorders , 2015, International Journal of Developmental Neuroscience.
[71] J. Calderón,et al. Increased homocysteine levels correlate with the communication deficit in children with autism spectrum disorder , 2015, Psychiatry Research.
[72] R. Sothern,et al. Measurement in saliva from neurotypical adults of biomarkers pertinent to autism spectrum disorders , 2015, Future science OA.
[73] Geir Bjorklund,et al. Acid glycosaminoglycan (aGAG) excretion is increased in children with autism spectrum disorder, and it can be controlled by diet , 2015, Metabolic Brain Disease.
[74] A. Legido,et al. Mitochondrial enzyme dysfunction in autism spectrum disorders; a novel biomarker revealed from buccal swab analysis. , 2015, Biomarkers in medicine.
[75] Geir Bjorklund,et al. A Randomized, Placebo-controlled Trial of Digestive Enzymes in Children with Autism Spectrum Disorders , 2015, Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology.
[76] K. J. Parker,et al. Arginine Vasopressin Is a Blood-Based Biomarker of Social Functioning in Children with Autism , 2015, PloS one.
[77] D. Macfabe. Enteric short-chain fatty acids: microbial messengers of metabolism, mitochondria, and mind: implications in autism spectrum disorders , 2015, Microbial ecology in health and disease.
[78] Tewarit Sarachana,et al. Investigation of sex differences in the expression of RORA and its transcriptional targets in the brain as a potential contributor to the sex bias in autism , 2015, Molecular Autism.
[79] Chunlin Yan,et al. Decreased plasma levels of lipoxin A4 in children with autism spectrum disorders , 2015, Neuroreport.
[80] Jin-gang Fan,et al. High plasma neopterin levels in Chinese children with autism spectrum disorders , 2015, International Journal of Developmental Neuroscience.
[81] K. Xia,et al. Elevated mitochondrial DNA copy number in peripheral blood cells is associated with childhood autism , 2015, BMC Psychiatry.
[82] Hoda G. Hegazy,et al. Interplay between pro-inflammatory cytokines and brain oxidative stress biomarkers: evidence of parallels between butyl paraben intoxication and the valproic acid brain physiopathology in autism rat model. , 2015, Cytokine.
[83] Si-ju Gao,et al. Thioredoxin: A novel, independent diagnosis marker in children with autism , 2015, International Journal of Developmental Neuroscience.
[84] Xiaohong Li,et al. Inflammatory Cytokines: Potential Biomarkers of Immunologic Dysfunction in Autism Spectrum Disorders , 2015, Mediators of inflammation.
[85] Xiaolin Zhu,et al. The combined role of serotonin and interleukin-6 as biomarker for autism , 2015, Neuroscience.
[86] Geir Bjorklund,et al. ADHD, autism and neuroradiological complications among phenylketonuric children in Upper Egypt , 2015, Acta Neurologica Belgica.
[87] S Baron-Cohen,et al. Elevated fetal steroidogenic activity in autism , 2014, Molecular Psychiatry.
[88] Y. Ozkul,et al. MTHFR Gene C677T Polymorphism in Autism Spectrum Disorders , 2014, Genetics research international.
[89] Karl J. Friston,et al. Neuroscience and Biobehavioral Reviews , 2014 .
[90] Geir Bjorklund,et al. Serum copper and zinc levels in individuals with autism spectrum disorders , 2014, Neuroreport.
[91] Geir Bjørklund,et al. Levels of Metals in the Blood and Specific Porphyrins in the Urine in Children with Autism Spectrum Disorders , 2014, Biological Trace Element Research.
[92] Brian S. Hooker,et al. A Dose-Response Relationship between Organic Mercury Exposure from Thimerosal-Containing Vaccines and Neurodevelopmental Disorders , 2014, International journal of environmental research and public health.
[93] A. El-Ansary,et al. Relative abundance of short chain and polyunsaturated fatty acids in propionic acid-induced autistic features in rat pups as potential markers in autism , 2014, Lipids in Health and Disease.
[94] S. Walitza,et al. Autism spectrum disorder associated with low serotonin in CSF and mutations in the SLC29A4 plasma membrane monoamine transporter (PMAT) gene , 2014, Molecular Autism.
[95] Robert L. Hendren,et al. Biomarkers in Autism , 2014, Front. Psychiatry.
[96] Eric Boerwinkle,et al. Role of Metabolic Genes in Blood Arsenic Concentrations of Jamaican Children with and without Autism Spectrum Disorder , 2014, International journal of environmental research and public health.
[97] Sarabeth Broder-Fingert,et al. Prevalence of overweight and obesity in a large clinical sample of children with autism. , 2014, Academic pediatrics.
[98] S. Dimauro,et al. Mitochondrial dysfunction as a neurobiological subtype of autism spectrum disorder: evidence from brain imaging. , 2014, JAMA psychiatry.
[99] E. Susser,et al. Parental Obesity and Risk of Autism Spectrum Disorder , 2014, Pediatrics.
[100] F. El-baz,et al. Study of plasma amino acid levels in children with autism: An Egyptian sample , 2014 .
[101] S. J. James,et al. Oxidative stress induces mitochondrial dysfunction in a subset of autistic lymphoblastoid cell lines , 2014, Translational Psychiatry.
[102] E. Minikel,et al. Autism Spectrum Disorder Genetics: Diverse Genes with Diverse Clinical Outcomes , 2014, Harvard review of psychiatry.
[103] D. Rossignol,et al. Environmental toxicants and autism spectrum disorders: a systematic review , 2014, Translational Psychiatry.
[104] M. Valentovic,et al. Transsulfuration Is a Significant Source of Sulfur for Glutathione Production in Human Mammary Epithelial Cells , 2013, ISRN biochemistry.
[105] K. Jamil,et al. Clinical Implications of MTHFR Gene Polymorphism in Various Diseases , 2014 .
[106] T. Boeckers,et al. Zinc deficiency dysregulates the synaptic ProSAP/Shank scaffold and might contribute to autism spectrum disorders. , 2014, Brain : a journal of neurology.
[107] A. El-Ansary,et al. Association of social and cognitive impairment and biomarkers in autism spectrum disorders , 2014, Journal of Neuroinflammation.
[108] Hiroshi Yasuda,et al. Assessment of Infantile Mineral Imbalances in Autism Spectrum Disorders (ASDs) , 2013, International journal of environmental research and public health.
[109] R. Rose'meyer. A review of the serotonin transporter and prenatal cortisol in the development of autism spectrum disorders , 2013, Molecular Autism.
[110] J. Wegiel,et al. Alterations in mitochondrial DNA copy number and the activities of electron transport chain complexes and pyruvate dehydrogenase in the frontal cortex from subjects with autism , 2013, Translational Psychiatry.
[111] D. Siniscalco,et al. Epigenetic Findings in Autism: New Perspectives for Therapy , 2013, International journal of environmental research and public health.
[112] P. Gorrindo,et al. Enrichment of Elevated Plasma F2t-Isoprostane Levels in Individuals with Autism Who Are Stratified by Presence of Gastrointestinal Dysfunction , 2013, PloS one.
[113] P. Abruzzo,et al. Oxidative Stress and Erythrocyte Membrane Alterations in Children with Autism: Correlation with Clinical Features , 2013, PloS one.
[114] Francine Laden,et al. Perinatal Air Pollutant Exposures and Autism Spectrum Disorder in the Children of Nurses’ Health Study II Participants , 2013, Environmental health perspectives.
[115] M. Michalska,et al. A focus on homocysteine in autism. , 2013, Acta biochimica Polonica.
[116] E. Susser,et al. Maternal folic acid supplementation and risk of autism--reply. , 2013, JAMA.
[117] S. J. James,et al. Redox metabolism abnormalities in autistic children associated with mitochondrial disease , 2013, Translational Psychiatry.
[118] Huey-Miin Hsueh,et al. The linear combinations of biomarkers which maximize the partial area under the ROC curves , 2013, Comput. Stat..
[119] Jong H. Yoon,et al. Oxytocin and Vasopressin in Children and Adolescents With Autism Spectrum Disorders: Sex Differences and Associations With Symptoms , 2013, Autism research : official journal of the International Society for Autism Research.
[120] Robert Kumsta,et al. Epigenetic regulation of the oxytocin receptor gene: implications for behavioral neuroscience , 2013, Front. Neurosci..
[121] O. Brack,et al. Distinct profiles of systemic biomarkers of oxidative stress in chronic human pathologies: Cardiovascular, psychiatric, neurodegenerative, rheumatic, infectious, neoplasmic and endocrinological diseases , 2013 .
[122] A. Depino. Peripheral and central inflammation in autism spectrum disorders , 2013, Molecular and Cellular Neuroscience.
[123] Per Magnus,et al. Association between maternal use of folic acid supplements and risk of autism spectrum disorders in children. , 2013, JAMA.
[124] R. Frye,et al. Unique acyl-carnitine profiles are potential biomarkers for acquired mitochondrial disease in autism spectrum disorder , 2013, Translational Psychiatry.
[125] Geir Bjorklund,et al. The role of zinc and copper in autism spectrum disorders. , 2013, Acta neurobiologiae experimentalis.
[126] Lisa K. Sykes,et al. Urinary Porphyrins in Autism Spectrum Disorders , 2013 .
[127] A. El-Ansary,et al. Neuroinflammation in autism spectrum disorders , 2012, Journal of Neuroinflammation.
[128] F. Orio,et al. Pervasive developmental disorders in children of hyperandrogenic women with polycystic ovary syndrome: a longitudinal case–control study , 2012, Clinical endocrinology.
[129] D. Rosenberg,et al. Mice Genetically Depleted of Brain Serotonin Display Social Impairments, Communication Deficits and Repetitive Behaviors: Possible Relevance to Autism , 2012, PloS one.
[130] Stephanie Seneff,et al. Impaired Sulfate Metabolism and Epigenetics: Is There a Link in Autism? , 2012, Entropy.
[131] Marion Leboyer,et al. Autism risk factors: genes, environment, and gene-environment interactions , 2012, Dialogues in clinical neuroscience.
[132] K. Reichelt,et al. Peptides’ role in autism with emphasis on exorphins , 2012, Microbial ecology in health and disease.
[133] H. Chen,et al. Application of LC-MS/MS analysis of plasma amino acids profiles in children with autism , 2012, Journal of clinical biochemistry and nutrition.
[134] M. Hepel,et al. Intervention of glutathione in pre-mutagenic catechol-mediated DNA damage in the presence of copper(II) ions. , 2012, Mutation research.
[135] S. J. James,et al. Evidence of oxidative damage and inflammation associated with low glutathione redox status in the autism brain , 2012, Translational Psychiatry.
[136] A. Sheikh,et al. Brain IL-6 elevation causes neuronal circuitry imbalances and mediates autism-like behaviors. , 2012, Biochimica et biophysica acta.
[137] Thomas Wisniewski,et al. Abnormal Intracellular Accumulation and Extracellular Aβ Deposition in Idiopathic and Dup15q11.2-q13 Autism Spectrum Disorders , 2012, PloS one.
[138] M. Fenech,et al. The potential role of the antioxidant and detoxification properties of glutathione in autism spectrum disorders: a systematic review and meta-analysis , 2012, Nutrition & Metabolism.
[139] D. Echeverria,et al. Disordered Porphyrin Metabolism: A Potential Biological Marker for Autism Risk Assessment , 2012, Autism research : official journal of the International Society for Autism Research.
[140] Jeremy Veenstra-VanderWeele,et al. Autism gene variant causes hyperserotonemia, serotonin receptor hypersensitivity, social impairment and repetitive behavior , 2012, Proceedings of the National Academy of Sciences.
[141] W. Gattaz,et al. Altered Neurotrophin, Neuropeptide, Cytokines and Nitric Oxide Levels in Autism , 2012, Pharmacopsychiatry.
[142] D. Gaylor,et al. Metabolic Imbalance Associated with Methylation Dysregulation and Oxidative Damage in Children with Autism , 2012, Journal of autism and developmental disorders.
[143] M. Kamboj,et al. Role of endocrine factors in autistic spectrum disorders. , 2012, Pediatric clinics of North America.
[144] D. Rossignol,et al. Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis , 2011, Molecular Psychiatry.
[145] P. Ashwood,et al. Autism spectrum disorders: from immunity to behavior. , 2012, Methods in molecular biology.
[146] K. Brady,et al. Enhanced Cortisol Response to Stress in Children in Autism , 2011, Journal of Autism and Developmental Disorders.
[147] Janet K. Kern,et al. An evaluation of the role and treatment of elevated male hormones in autism spectrum disorders. , 2012, Acta neurobiologiae experimentalis.
[148] H. Brenner,et al. Neuregulin/ErbB regulate neuromuscular junction development by phosphorylation of α-dystrobrevin , 2011, The Journal of cell biology.
[149] Janet K. Kern,et al. A clinical trial of glutathione supplementation in autism spectrum disorders , 2011, Medical science monitor : international medical journal of experimental and clinical research.
[150] A. El-Ansary,et al. Novel metabolic biomarkers related to sulfur-dependent detoxification pathways in autistic patients of Saudi Arabia , 2011, BMC neurology.
[151] S. Viville,et al. Autism, imprinting and epigenetic disorders: a metabolic syndrome linked to anomalies in homocysteine recycling starting in early life?? , 2011, Journal of Assisted Reproduction and Genetics.
[152] R. Perlis,et al. Translating biomarkers to clinical practice , 2011, Molecular Psychiatry.
[153] M. Angley,et al. A review of candidate urinary biomarkers for autism spectrum disorder , 2011, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.
[154] A. El-Ansary,et al. Proinflammatory and proapoptotic markers in relation to mono and di-cations in plasma of autistic patients from Saudi Arabia , 2011, Journal of Neuroinflammation.
[155] Lakshmi Priya Malarveni Damodaran,et al. Urinary oxidative stress markers in children with autism , 2011, Redox report : communications in free radical research.
[156] A. Bacha,et al. Relationship between chronic lead toxicity and plasma neurotransmitters in autistic patients from Saudi Arabia. , 2011, Clinical biochemistry.
[157] I. Cohen,et al. Population- and Family-Based Studies Associate the MTHFR Gene with Idiopathic Autism in Simplex Families , 2011, Journal of autism and developmental disorders.
[158] David Quig,et al. Nutritional and metabolic status of children with autism vs. neurotypical children, and the association with autism severity , 2011, Nutrition & metabolism.
[159] V. Eapen. Genetic basis of autism: is there a way forward? , 2011, Current opinion in psychiatry.
[160] A. El-Ansary,et al. Impaired plasma phospholipids and relative amounts of essential polyunsaturated fatty acids in autistic patients from Saudi Arabia , 2011, Lipids in Health and Disease.
[161] J. Wegiel,et al. Brain region‐specific deficit in mitochondrial electron transport chain complexes in children with autism , 2011, Journal of neurochemistry.
[162] M. Hepel,et al. Antioxidant Effectiveness in Preventing Paraquat-Mediated Oxidative DNA Damage in the Presence of H2O2 , 2011 .
[163] N. Meguid,et al. Evaluation of Oxidative Stress in Autism: Defective Antioxidant Enzymes and Increased Lipid Peroxidation , 2011, Biological Trace Element Research.
[164] J. Sutcliffe,et al. Association of oxytocin receptor (OXTR) gene variants with multiple phenotype domains of autism spectrum disorder , 2011, Journal of Neurodevelopmental Disorders.
[165] R. Dubner,et al. Interactions between the immune and nervous systems in pain , 2010, Nature Medicine.
[166] M. Hepel,et al. Interactions of Herbicide Atrazine With DNA , 2010 .
[167] R. Mckinnon,et al. Is there a role for routinely screening children with autism spectrum disorder for creatine deficiency syndrome? , 2010, Autism research : official journal of the International Society for Autism Research.
[168] R. Reading,et al. Clinical genetic testing for patients with autism spectrum disorders , 2010 .
[169] D. Echeverria,et al. Urinary Porphyrin Excretion in Neurotypical and Autistic Children , 2010, Environmental health perspectives.
[170] M. Fenech,et al. Folate and methionine metabolism in autism: a systematic review. , 2010, The American journal of clinical nutrition.
[171] Erik T Parner,et al. Maternal Infection Requiring Hospitalization During Pregnancy and Autism Spectrum Disorders , 2010, Journal of autism and developmental disorders.
[172] J. Prandota. Neuropathological changes and clinical features of autism spectrum disorder participants are similar to that reported in congenital and chronic cerebral toxoplasmosis in humans and mice , 2010 .
[173] Sharyn A. Lincoln,et al. Clinical Genetic Testing for Patients With Autism Spectrum Disorders , 2010, Pediatrics.
[174] Per Magnus,et al. THE AUTISM BIRTH COHORT (ABC): A PARADIGM FOR GENE-ENVIRONMENT-TIMING RESEARCH , 2010, Molecular Psychiatry.
[175] A. El-Ansary,et al. Metabolic biomarkers related to oxidative stress and antioxidant status in Saudi autistic children. , 2009, Clinical biochemistry.
[176] D. Zafeiriou,et al. The Serotonergic System: Its Role in Pathogenesis and Early Developmental Treatment of Autism , 2009, Current neuropharmacology.
[177] H. M. Skip Kingston,et al. The plasma zinc/serum copper ratio as a biomarker in children with autism spectrum disorders , 2009, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.
[178] Sangita B. Patil,et al. Elevated immune response in the brain of autistic patients , 2009, Journal of Neuroimmunology.
[179] A. Kobal. Possible influence of mercury on pathogenesis of autism. , 2009 .
[180] D. Winge,et al. “ Pulling the plug ” on cellular copper : The role of mitochondria in copper export , 2008 .
[181] J. Kern,et al. A Prospective Study of Transsulfuration Biomarkers in Autistic Disorders , 2009, Neurochemical Research.
[182] Janet K. Kern,et al. A Prospective Study of Transsulfuration Biomarkers in Autistic Disorders , 2009, Neurochemical Research.
[183] Bruce H. Cohen,et al. Mitochondrial Disease in Autism Spectrum Disorder Patients: A Cohort Analysis , 2008, PloS one.
[184] Kjetil Søreide,et al. Receiver-operating characteristic curve analysis in diagnostic, prognostic and predictive biomarker research , 2008, Journal of Clinical Pathology.
[185] E. Rogers. Has enhanced folate status during pregnancy altered natural selection and possibly Autism prevalence? A closer look at a possible link. , 2008, Medical hypotheses.
[186] P. Moretti,et al. Brief Report: Autistic Symptoms, Developmental Regression, Mental Retardation, Epilepsy, and Dyskinesias in CNS Folate Deficiency , 2008, Journal of autism and developmental disorders.
[187] Nenad Blau,et al. A milk‐free diet downregulates folate receptor autoimmunity in cerebral folate deficiency syndrome , 2008, Developmental medicine and child neurology.
[188] G. B. Schaefer,et al. Clinical genetics evaluation in identifying the etiology of autism spectrum disorders , 2008, Genetics in Medicine.
[189] Paolo Curatolo,et al. Autism and Metabolic Diseases , 2008, Journal of child neurology.
[190] R. Deth,et al. How environmental and genetic factors combine to cause autism: A redox/methylation hypothesis. , 2008, Neurotoxicology.
[191] N. Blau,et al. Folate receptor autoimmunity and cerebral folate deficiency in low-functioning autism with neurological deficits. , 2007, Neuropediatrics.
[192] David A Geier,et al. A prospective assessment of androgen levels in patients with autistic spectrum disorders: biochemical underpinnings and suggested therapies. , 2007, Neuro endocrinology letters.
[193] M. Chez,et al. Elevation of tumor necrosis factor-alpha in cerebrospinal fluid of autistic children. , 2007, Pediatric neurology.
[194] C. Sala,et al. DNA methylation regulates tissue‐specific expression of Shank3 , 2007, Journal of neurochemistry.
[195] M. Noble,et al. Chemically Diverse Toxicants Converge on Fyn and c-Cbl to Disrupt Precursor Cell Function , 2007, PLoS biology.
[196] Simon Gilbody,et al. Methylenetetrahydrofolate reductase (MTHFR) genetic polymorphisms and psychiatric disorders: a HuGE review. , 2006, American journal of epidemiology.
[197] Jun-Ming Zhang,et al. Cytokines, Inflammation, and Pain , 2007, International anesthesiology clinics.
[198] A. Holmgren,et al. Thioredoxin and related molecules--from biology to health and disease. , 2007, Antioxidants & redox signaling.
[199] J. Pincemail,et al. [Oxidative stress]. , 2007, Revue medicale de Liege.
[200] P. Landrigan,et al. Developmental neurotoxicity of industrial chemicals , 2006, The Lancet.
[201] A. Chauhan,et al. Oxidative stress in autism. , 2006, Pathophysiology : the official journal of the International Society for Pathophysiology.
[202] Nathalie Boddaert,et al. Autism, the superior temporal sulcus and social perception , 2006, Trends in Neurosciences.
[203] F. George,et al. Analyses of toxic metals and essential minerals in the hair of arizona children with autism and associated conditions, and their mothers , 2006, Biological Trace Element Research.
[204] L. López-Carrillo,et al. Methylenetetrahydrofolate reductase 677C>T polymorphism and gastric cancer susceptibility in Mexico. , 2006, European journal of cancer.
[205] Janet K. Kern,et al. Evidence of Toxicity, Oxidative Stress, and Neuronal Insult in Autism , 2006, Journal of toxicology and environmental health. Part B, Critical reviews.
[206] Eric E. Schadt,et al. Glyoxalase 1 and glutathione reductase 1 regulate anxiety in mice , 2005, Nature.
[207] T P Stein,et al. Increased excretion of a lipid peroxidation biomarker in autism. , 2005, Prostaglandins, leukotrienes, and essential fatty acids.
[208] Nenad Blau,et al. Autoantibodies to folate receptors in the cerebral folate deficiency syndrome. , 2005, The New England journal of medicine.
[209] R. Finnell,et al. Cerebral folate deficiency with developmental delay, autism, and response to folinic acid , 2005, Neurology.
[210] G. Oliveira,et al. Mitochondrial dysfunction in autism spectrum disorders: a population-based study. , 2005, Developmental medicine and child neurology.
[211] Samantha A. Stewart. The effects of benzodiazepines on cognition. , 2005, The Journal of clinical psychiatry.
[212] A. Zimmerman,et al. Neuroglial activation and neuroinflammation in the brain of patients with autism , 2005, Annals of neurology.
[213] C. McDougle,et al. Neurochemistry in the pathophysiology of autism. , 2005, The Journal of clinical psychiatry.
[214] N. Blau,et al. Cerebral folate deficiency , 2004, Developmental medicine and child neurology.
[215] David W Gaylor,et al. Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism. , 2004, The American journal of clinical nutrition.
[216] C. Costa,et al. Zinc/copper imbalance reflects immune dysfunction in human leishmaniasis: an ex vivo and in vitro study , 2004, BMC infectious diseases.
[217] W. Brown,et al. Oxidative stress in autism: increased lipid peroxidation and reduced serum levels of ceruloplasmin and transferrin--the antioxidant proteins. , 2004, Life sciences.
[218] C. F. Fischer Walker,et al. Zinc and the risk for infectious disease. , 2004, Annual review of nutrition.
[219] S. Zoroglu,et al. Increased oxidative stress and altered activities of erythrocyte free radical scavenging enzymes in autism , 2004, European Archives of Psychiatry and Clinical Neuroscience.
[220] C. McDougle,et al. High nitric oxide production in autistic disorder: a possible role for interferon-γ , 2004, Biological Psychiatry.
[221] I L Cohen,et al. Association of autism severity with a monoamine oxidase A functional polymorphism , 2003, Clinical genetics.
[222] H. Savaş,et al. Changes in nitric oxide levels and antioxidant enzyme activities may have a role in the pathophysiological mechanisms involved in autism. , 2003, Clinica chimica acta; international journal of clinical chemistry.
[223] C. Marini,et al. Urinary Nitric Oxide Metabolites and Lipid Peroxidation By-Products in Migraine , 2003, Cephalalgia : an international journal of headache.
[224] N. Blau,et al. Psychomotor retardation, spastic paraplegia, cerebellar ataxia and dyskinesia associated with low 5-methyltetrahydrofolate in cerebrospinal fluid: a novel neurometabolic condition responding to folinic acid substitution. , 2003, Neuropediatrics.
[225] O. Yorbik,et al. Investigation of antioxidant enzymes in children with autistic disorder. , 2002, Prostaglandins, leukotrienes, and essential fatty acids.
[226] E. Anyanwu,et al. Antibodies to neuron-specific antigens in children with autism: possible cross-reaction with encephalitogenic proteins from milk, Chlamydia pneumoniae and Streptococcus group A , 2002, Journal of Neuroimmunology.
[227] G. Bing,et al. Oxidative damage causes formation of lipofuscin-like substances in the hippocampus of the senescence-accelerated mouse after kainate treatment , 2002, Behavioural Brain Research.
[228] J. Yodoi,et al. Thioredoxin as a biomarker for oxidative stress in patients with rheumatoid arthritis. , 2002, Molecular immunology.
[229] A. Hardan,et al. A retrospective open trial of adjunctive donepezil in children and adolescents with autistic disorder. , 2002, Journal of child and adolescent psychopharmacology.
[230] T. Kemper,et al. Density and Distribution of Hippocampal Neurotransmitter Receptors in Autism: An Autoradiographic Study , 2001, Journal of autism and developmental disorders.
[231] E K Perry,et al. Cholinergic activity in autism: abnormalities in the cerebral cortex and basal forebrain. , 2001, The American journal of psychiatry.
[232] A. Nunomura,et al. Mitochondrial abnormalities in Alzheimer disease , 2000, Neurobiology of Aging.
[233] W. Streit,et al. Microglial Response to Brain Injury: A Brief Synopsis , 2000, Toxicologic pathology.
[234] J. Papadimitriou,et al. Gastrointestinal abnormalities in children with autistic disorder. , 1999, The Journal of pediatrics.
[235] J. Cravedi,et al. Identification of novel urinary metabolites of the lipid peroxidation product 4-hydroxy-2-nonenal in rats. , 1998, Chemical research in toxicology.
[236] J. Truman,et al. Nitric oxide-sensitive guanylate cyclase activity is associated with the maturational phase of neuronal development in insects. , 1996, Development.
[237] J. Yodoi,et al. A novel promoter sequence is involved in the oxidative stress-induced expression of the adult T-cell leukemia-derived factor (ADF)/human thioredoxin (Trx) gene. , 1996, Nucleic acids research.
[238] M. Roederer,et al. Elevation of plasma thioredoxin levels in HIV-infected individuals. , 1996, International immunology.
[239] F. Barone,et al. Cytokines, inflammation, and brain injury: role of tumor necrosis factor-alpha. , 1994, Cerebrovascular and brain metabolism reviews.
[240] S. Rose,et al. An inhibitor of nitric oxide synthesis prevents memory formation in the chick , 1992, Neuroscience Letters.
[241] K. Johnson,et al. Nitric oxide induces neurotransmitter release from hippocampal slices. , 1992, European journal of pharmacology.
[242] Mitchell H. Gail,et al. A family of nonparametric statistics for comparing diagnostic markers with paired or unpaired data , 1989 .
[243] J. Hibbs,et al. Nitric oxide: a cytotoxic activated macrophage effector molecule. , 1988, Biochemical and biophysical research communications.
[244] C. Metz. ROC Methodology in Radiologic Imaging , 1986, Investigative radiology.
[245] J. Swets. Indices of discrimination or diagnostic accuracy: their ROCs and implied models. , 1986, Psychological bulletin.
[246] J. Swets. ROC analysis applied to the evaluation of medical imaging techniques. , 1979, Investigative radiology.
[247] T. Buckler. Art. X.—On the Use of the Phosphate of Ammonia, as a new remedy for Gout and Rheumatism, as a solvent of uric acid calculus, and for diseases, acute and chronic, connected directly with the lithic acid diathesis. , 1846 .